These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19643440)

  • 1. Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome.
    Ross JL; Mazzocco MM; Kushner H; Kowal K; Cutler GB; Roeltgen D
    J Pediatr; 2009 Nov; 155(5):714-20. PubMed ID: 19643440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Visser M; Kreukels BP; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM; Cohen-Kettenis PT
    Horm Behav; 2010 Mar; 57(3):297-305. PubMed ID: 20053349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; van Koningsbrugge SH; de Ridder MA; Zandwijken GR; Boersma B; Dejonckere PH; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA; Sas TC; de Muinck Keizer-Schrama SM; Zandwijken GR; de Ridder MA; Odink RJ; Jansen M; Delemarre-van de Waal HA; Stokvis-Brantsma WH; Waelkens JJ; Westerlaken C; Reeser HM; van Trotsenburg AS; Gevers EF; van Buuren S; Dejonckere PH; Hokken-Koelega AC; Otten BJ; Wit JM
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Stijnen T; Zandwijken GR; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Horm Res Paediatr; 2011 Feb; 75(2):115-22. PubMed ID: 20814189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of oxandrolone in growth hormone-treated girls with Turner syndrome: evidence from recent studies and recommendations for use.
    Sas TC; Gault EJ; Bardsley MZ; Menke LA; Freriks K; Perry RJ; Otten BJ; de Muinck Keizer-Schrama SM; Timmers H; Wit JM; Ross JL; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):289-97. PubMed ID: 24776783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of previous oxandrolone treatment in adult women with Turner syndrome.
    Freriks K; Sas TC; Traas MA; Netea-Maier RT; den Heijer M; Hermus AR; Wit JM; van Alfen-van der Velden JA; Otten BJ; de Muinck Keizer-Schrama SM; Gotthardt M; Dejonckere PH; Zandwijken GR; Menke LA; Timmers HJ
    Eur J Endocrinol; 2013 Jan; 168(1):91-9. PubMed ID: 23076845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P; Massarano AA; Stanhope R
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.
    Menke LA; Sas TC; Zandwijken GR; de Ridder MA; Stijnen T; de Muinck Keizer-Schrama SM; Otten BJ; Wit JM
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):212-9. PubMed ID: 20105186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oxandrolone and timing of oral ethinylestradiol initiation on pubertal progression, height velocity and bone maturation in the UK Turner study.
    Perry RJ; Gault EJ; Paterson WF; Dunger DB; Donaldson MD
    Horm Res Paediatr; 2014; 81(5):298-308. PubMed ID: 24751470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome.
    Freriks K; Verhaak CM; Sas TC; Menke LA; Wit JM; Otten BJ; de Muinck Keizer-Schrama SM; Smeets DF; Netea-Maier RT; Hermus AR; Kessels RP; Timmers HJ
    Horm Behav; 2015 Mar; 69():59-67. PubMed ID: 25562712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities.
    Rudman D; Goldsmith M; Kutner M; Blackston D
    J Pediatr; 1980 Jan; 96(1):132-5. PubMed ID: 7350294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of bone mass in Turner syndrome].
    Cancer Gaspar E; Ruiz-Echarri Zelaya M; Labarta Aizpún JI; Mayayo Dehesa E; Ferrández Longás A
    An Pediatr (Barc); 2005 May; 62(5):441-9. PubMed ID: 15871826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):79-84. PubMed ID: 15996336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen-responsive aspects of cognition in girls with Turner syndrome.
    Ross JL; Roeltgen D; Stefanatos GA; Feuillan P; Kushner H; Bondy C; Cutler GB
    J Clin Endocrinol Metab; 2003 Jan; 88(1):292-6. PubMed ID: 12519868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematics learning disabilities in girls with fragile X or Turner syndrome during late elementary school.
    Murphy MM; Mazzocco MM
    J Learn Disabil; 2008; 41(1):29-46. PubMed ID: 18274502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG; Hintz RL; Johanson AJ; Brasel JA; Burstein S; Chernausek SD; Clabots T; Frane J; Gotlin RW; Kuntze J
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of growth hormone monotherapy and growth hormone in combination with oxandrolone or testosterone on thyroxid hormone parameters and thyroxine binding globulin in patients with Ullrich-Turner syndrome.
    Schmitt K; Häusler G; Blümel P; Plöchl E; Waldhör T; Frisch H
    Eur J Pediatr; 1997 Feb; 156(2):99-103. PubMed ID: 9039510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.